PAX6 Is Expressed in Pancreatic Cancer and Actively Participates in Cancer Progression through Activation of the MET Tyrosine Kinase Receptor Gene
Open Access
- 1 October 2009
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (40), 27524-27532
- https://doi.org/10.1074/jbc.m109.047209
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- The Met tyrosine kinase receptor in development and cancerCancer and Metastasis Reviews, 2008
- PAX6 is expressed in pancreatic adenocarcinoma and is downregulated during induction of terminal differentiationMolecular Carcinogenesis, 2007
- A new approach to managing intraductal papillary mucinous pancreatic neoplasmsGut, 2007
- PAX6 Suppresses the Invasiveness of Glioblastoma Cells and the Expression of the Matrix Metalloproteinase-2 GeneCancer Research, 2006
- The Pax6 isoform bearing an alternative spliced exon promotes the development of the neural retinal structureHuman Molecular Genetics, 2005
- Transcriptional activation of the Hepatocyte Growth Factor receptor (c-met) gene by its ligand (Hepatocyte Growth Factor) is mediated through AP-1Oncogene, 2000
- Missense Mutation in the Alternative Splice Region of the PAX6 Gene in Eye AnomaliesAmerican Journal of Human Genetics, 1999
- Comparative Phenotypic Studies of Duct Epithelial Cell Lines Derived from Normal Human Pancreas and Pancreatic CarcinomaThe American Journal of Pathology, 1998
- Alternative Splicing ofPax6in Bovine Eye and Evolutionary Conservation of Intron SequencesBiochemical and Biophysical Research Communications, 1997
- Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.The Journal of cell biology, 1993